Bacteriophages against Salmonella enterica: challenges and opportunities.

ABSTRACT: Salmonella spp. is the most common pathogen transmitted to humans through contaminated water and food. Due to its ability to infect both animals and humans, as well as the spread of antibiotic-resistant strains, this pathogen has become a priority for food and pharmaceutical industries. Consequently, research and development of treatments to combat infections caused by Salmonella spp. are ongoing. One of the most promising strategies is the phage therapy (PT) which is based on the use of very specific viruses that infect this pathogenic bacterium without any action over the host and which use has shown effectiveness. Now a days, at least 41 companies worldwide market phage therapy products mainly for use in the food sector to reduce the transmission chain of Salmonella spp. to humans. Howe

SUBMITTER: Segundo-Arizmendi N 

PROVIDER: S-EPMC12369589 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature